A method of inhibiting immunostimulatory DNA-associated responses in a subject, the method comprising administering a therapeutically effective amount of a composition to a subject exhibiting immunostimulatory DNA-associated responses, the composition comprising a compound having the structural formula B wherein, RB is a hydrogen atom, or an alkyl secondary or tertiary amino substituent selected f